Form4insider filings, from the source

SEC Form 4 · accession 0000904454-17-000741

Dicerna Pharmaceuticals Inc · DRNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
10% Owner
Brian H Dovey
10% Owner
Brian K Halak
Director · 10% Owner
Period of report
Dec 18, 2017
Accepted (ET)
Dec 20, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3Dec 18, 2017C12,444$3.19A25,448D
Common StockF4,F3Dec 18, 2017A282—A25,730D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Redeemable Convertible Preferred StockF3,F1,F2$3.19Dec 18, 2017C368D——Common Stock12,4440D

Explanation of responses

Remarks

This Form 4 does not constitute an exit filing for Brian K. Halak, a Director of the Issuer.